Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy

Ling Zhang1, Chengguang Sui1, Wenhan Yang2,3

  • 1Department of Biotherapy, The First Affiliated Hospital of China Medical University, Shenyang 110001, China.

Insights

Amino acid transporters are highly expressed in tumors, offering a promising target for cancer therapy. This review explores their role in tumor growth and novel drug delivery strategies for targeted treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Pharmacology

Background:

  • Amino acid transporters are crucial for mammalian cell biosynthesis and are often overexpressed in various tumor types.
  • Their elevated expression in cancer cells presents a viable target for developing novel tumor-targeting therapies.

Purpose of the Study:

  • To review tumor-related amino acid transporters and their potential applications in cancer therapy.
  • To discuss the recognition requirements of these transporters, including acid-base properties, isomerism, and structural analogues.
  • To highlight recent advancements in drug delivery strategies targeting amino acid transporters, such as prodrugs and nanocarriers.

Main Methods:

  • Review of existing literature on amino acid transporter expression in cancer.
  • Analysis of transporter recognition mechanisms (acid-base properties, conformational isomerism, structural analogues).
  • Examination of current drug delivery strategies, including prodrugs and nanocarriers, focusing on transporter-mediated endocytosis.

Main Results:

  • Amino acid transporters show distinct expression patterns in cancer, correlating with tumor progression.
  • Understanding transporter recognition is key to designing effective targeting agents.
  • Prodrugs and nanocarriers show promise for targeted delivery via transporter-mediated endocytosis.

Conclusions:

  • Amino acid transporters represent a significant target for innovative cancer therapies.
  • Further research into transporter mechanisms and drug delivery systems can lead to more effective tumor-targeting strategies.
  • Targeting amino acid transporters offers a promising avenue for enhancing the efficacy of cancer treatments.

Related Concept Videos

Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
893
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
5.5K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
1.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.8K